Darzalex

Darzalex Chỉ định/Công dụng

daratumumab

Nhà sản xuất:

Janssen-Cilag
Thông tin kê toa chi tiết tiếng Anh
Indications/Uses
DARZALEX is indicated: as monotherapy for the treatment of adult patients with relapsed and refractory multiple myeloma, whose prior therapy included a proteasome inhibitor and an immunomodulatory agent and who have demonstrated disease progression on the last therapy; in combination with lenalidomide and dexamethasone, or bortezomib and dexamethasone, for the treatment of adult patients with multiple myeloma who have received at least one prior therapy.
Register or sign in to continue
Asia's one-stop resource for medical news, clinical reference and education
Sign up for free
Already a member? Sign in